Abstract-Vascular injury and remodeling are common pathological sequelae of hypertension. Previous studies have suggested that the renin-angiotensin system acting through the type 1 angiotensin II (AT 1 ) receptor promotes vascular pathology in hypertension. To study the role of AT 1 receptors in this process, we generated mice with cell-specific deletion of AT 1 receptors in vascular smooth muscle cells using (SMKO) mice, AT 1A receptors were efficiently deleted from vascular smooth muscle cells in larger vessels but not from resistance vessels such as preglomerular arterioles. Thus, vasoconstrictor responses to angiotensin II were preserved in SMKO mice. To induce hypertensive vascular remodeling, mice were continuously infused with angiotensin II for 4 weeks. During infusion of angiotensin II, blood pressures increased significantly and to a similar extent in SMKO and control mice. In control mice, there was evidence of vascular oxidative stress indicated by enhanced nitrated tyrosine residues in segments of aorta; this was significantly attenuated in SMKO mice. Despite these differences in oxidative stress, the extent of aortic medial expansion induced by angiotensin II infusion was virtually identical in both groups. Thus, vascular AT 1A receptors promote oxidative stress in the aortic wall but are not required for remodeling in angiotensin II-dependent hypertension. (Hypertension. 2011;57:00-00.) • Online Data Supplement Key Words: angiotensin II Ⅲ hypertrophy Ⅲ hyperplasia Ⅲ aorta Ⅲ smooth muscle Ⅲ hypertension T he renin-angiotensin system (RAS) is a principal regulator of blood pressure homeostasis; dysregulation of this system commonly contributes to human hypertension. 1,2 Accordingly, pharmacological inhibitors of the RAS, including angiotensin converting enzyme inhibitors and angiotensin receptor blockers, can effectively lower blood pressure in a significant proportion of patients with essential hypertension. 3, 4 Moreover, these agents also attenuate end-organ damage, decreasing cardiovascular morbidity, and slowing the progression of chronic kidney injury. 5, 6 It has been suggested that RAS inhibitors provide protection against complications of hypertension beyond their effects to lower blood pressure, indicating nonhemodynamic, cellular actions of angiotensin II to promote tissue damage. 7 However, in some clinical trials, end-organ protection by RAS inhibition has been accompanied by more effective reduction of blood pressure. 4, 8, 9 Moreover, studies in animal models have suggested that the antihypertensive actions of RAS inhibitors are critical for preventing cardiac hypertrophy 10 and progressive kidney injury. 11 The vascular system is a major target of damage in hypertension. Expansion of arteries and arterioles in the kidney, also called nephrosclerosis, is the most common renal pathological lesion accompanying hypertension 12 and is an important cause of chronic kidney disease in blacks. 13 Vessel remodeling with changes in compliance is also seen in the aorta and other vascular beds in hypertension, 14 in which the RAS has potent actions to influence vascular structure and function. 15 For example, angiotensin II causes systemic vasoconstriction by activa-
T he renin-angiotensin system (RAS) is a principal regulator of blood pressure homeostasis; dysregulation of this system commonly contributes to human hypertension. 1, 2 Accordingly, pharmacological inhibitors of the RAS, including angiotensin converting enzyme inhibitors and angiotensin receptor blockers, can effectively lower blood pressure in a significant proportion of patients with essential hypertension. 3, 4 Moreover, these agents also attenuate end-organ damage, decreasing cardiovascular morbidity, and slowing the progression of chronic kidney injury. 5, 6 It has been suggested that RAS inhibitors provide protection against complications of hypertension beyond their effects to lower blood pressure, indicating nonhemodynamic, cellular actions of angiotensin II to promote tissue damage. 7 However, in some clinical trials, end-organ protection by RAS inhibition has been accompanied by more effective reduction of blood pressure. 4, 8, 9 Moreover, studies in animal models have suggested that the antihypertensive actions of RAS inhibitors are critical for preventing cardiac hypertrophy 10 and progressive kidney injury. 11 The vascular system is a major target of damage in hypertension. Expansion of arteries and arterioles in the kidney, also called nephrosclerosis, is the most common renal pathological lesion accompanying hypertension 12 and is an important cause of chronic kidney disease in blacks. 13 Vessel remodeling with changes in compliance is also seen in the aorta and other vascular beds in hypertension, 14 in which the RAS has potent actions to influence vascular structure and function. 15 For example, angiotensin II causes systemic vasoconstriction by activa-tion of angiotensin II type 1 (AT 1 ) receptors in vascular smooth muscle cells (VSMCs). 16 Along with their effects on vascular tone, AT 1 receptors may also stimulate growth and hypertrophy of VSMCs, 17 thereby directly contributing to vascular remodeling in hypertension. It has been suggested that nonhemodynamic actions of AT 1 receptors, including enhanced generation of reactive oxygen species (ROS), may promote changes in vascular structure that perpetuate the development of hypertension. 14 Further, angiotensin II receptor blockers reverse vascular remodeling in patients with hypertension, suggesting a direct role for vascular AT 1 receptors in this process. 18 Nonetheless, the precise role of AT 1 receptors in individual tissues is difficult to discern through experiments using pharmacological inhibitors or conventional gene targeting, in which actions of AT 1 receptors are abrogated in all tissues, and changes in blood pressure may further confound interpretations. Accordingly, we generated mice with cell-specific deletion of AT 1A receptors from smooth muscle cells in conduit vessels that are subject to hypertensive remodeling. During angiotensin II-dependent hypertension, we find reduced oxidative stress in vascular segments lacking AT 1A receptors, but vascular remodeling is unaffected.
Methods

Generation of Experimental Animals
A mouse line with a conditional Agtr1a allele was generated using homologous recombination in embryonic stem cells as described (Gurley et al, unpublished data; also see online data supplement, available at http://hyper.ahajournals.org). 19 SM22␣-Cre mice were purchased from The Jackson Laboratory (stock No. 004746). Mice were bred and maintained in the Association for Assessment and Accreditation of Laboratory Animal Care-accredited animal facilities at the Durham VA Medical Center according to National Institutes of Health guidelines. All of the animal studies were approved by the Durham Veterans' Affairs Medical Center Institutional Animal Care and Use Committee and conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Animals had free access to standard rodent chow and water unless specified. Eight-to 12-week-old male mice and littermate controls were used for experiments.
Isolation of Preglomerular Vessels for Receptor Expression Analysis
Afferent arterioles and interlobular arteries were isolated from kidneys using a modified iron oxide-sieving technique according to Chatziantoniou et al. 20, 21 The enriched preparation of preglomerular arteries and arterioles was transferred to a tube containing RNAlater and stored at 4°C for 24 hours, then at Ϫ80°C.
Measurement of AT 1A mRNA Levels and RT-PCR
Relative levels of mRNA for the AT 1A receptor in various tissues were determined by real-time RT-PCR with the ABI Prism 7700 sequence detection system as described. 22 Tissues were harvested, and total RNA was isolated using TRI Reagent (Sigma-Aldrich) per manufacturer instructions. The number of copies of the PCR template in the starting sample is calculated using the Sequence Detector Software incorporated in the ABI Prism 7700 Sequence Detector System. For each experimental sample, the amounts of the target and of the endogenous control were determined from the appropriate standard curves or relative values were determined using the ⌬⌬CT method (Applied Biosystems).
Isometric Force Measurements in Aortic and Mesenteric Rings
Aortic and mesenteric artery rings were mounted in a wire myograph as described previously. 23 Dose-response curves were generated for phenylephrine and angiotensin II. Forces are expressed as a percentage of the maximal response to phenylephrine, and this was equivalent between groups.
Assessment of Acute Vasoconstrictor Responses
Our previous studies showed that vasoconstrictor responses to acute administration of angiotensin II are almost completely extinguished in mice with complete AT 1A receptor deficiency. 24 Therefore, to determine the veracity of the deletion of vascular AT 1A receptors, we examined acute pressor responses to angiotensin II as described previously. 24 At 5-minute intervals, increasing doses (0.1, 1, and 10 g/kg) of angiotensin II (Sigma-Aldrich) or 10 g/kg of epinephrine (Sigma-Aldrich) were injected intravenously while intra-arterial pressures were continuously monitored.
Blood Pressure Measurements in Conscious Mice
Blood pressures were measured in 8-to 12-week-old male conscious SM22␣-Cre ϩ Agtr1a flox/flox (SMKO) and control mice using radiotelemetry, as described previously. 25 During the measurement period, mice were housed in a monitoring room where quiet is maintained and no other experiments are performed. Arterial blood pressures were collected, stored, and analyzed using Dataquest A. R. T. software (version 4.0; Transoma Medical). Measurements were recorded over a 10-second interval every 5 minutes at baseline and during 21 days, where angiotensin II was infused chronically (1000 ng/kg/min) by osmotic mini-pump (Alzet).
Analysis of Oxidized Amino Acids in Aortae
After 28 days of angiotensin II infusion, thoracic aortae were dissected from control and SMKO mice and immediately placed in antioxidant buffer (100 mol/L diethylene tetramino pentaacetic acid (metal chelator), 50 mol/L butylated hydroxytoluene (lipidsoluble antioxidant), 10 L/mL protease inhibitor (Halt Protease Inhibitor Cocktail; Pierce) in 50 mmol/L sodium phosphate buffer, pH 7.4) at Ϫ80°C. Amino acids were isolated from the acid hydrolysate using a solid-phase column (Supelclean ENVI ChromP column; Supelco Inc.) as described. 26 Oxidized amino acids were quantified by liquid chromatography-electrospray ionization tandem mass spectrometry using multiple reaction monitoring mode. Under these chromatography conditions, authentic compounds and isotopically labeled standards were baseline separated and exhibited retention times identical to those of analytes derived from tissue samples. 3-nitrotyrosine and dityrosine were detected by characteristic liquid chromatography retention time and specific ion transitions in the multiple reaction monitoring mode. The ratio of the peak areas of the analyte with corresponding 13 C internal standard were used to quantify levels of oxidized amino acids in tissue. Results are normalized to protein content of tyrosine, the precursor of 3-nitrotyrosine and dityrosine.
Measurement of Hydrogen Peroxide Production in Aortae
Hydrogen peroxide (H 2 O 2 ) of freshly prepared thoracic aorta from both SMKO and control mice (nϭ3 for both) were measured with the Amplex Red H 2 O 2 Assay Kit (Molecular Probes). Thoracic aortae were harvested, and adventitial tissue was dissected free in ice-cold Krebs-Henseleit buffer. After opening the aorta with scissors and washing out the blood, the aorta was incubated in the reaction mixture for 60 minutes in the dark at 37°C. The supernatant was then read in a fluorescent spectrophotometry according to the protocol provided by the manufacturer. The fluorescent values were normalized to the protein content measured in each sample (BioRad).
Measurement of Medial Thickness, Medial Area, and Luminal Area of Aortae
The extent of vascular pathology was assessed by measuring medial thickness of descending thoracic aorta. Two centimeters of descending aorta was dissected in animals that were fixed and perfused with 4% paraformaldehyde and placed in 10% formalin overnight. Tenmicrometer sections were obtained after paraffin embedding. Sections were stained with hematoxalin and eosin, and photographs were taken at 40ϫ and 10ϫ (Zeiss Axio Imager; QImaging MicroPublisher 5.0 MP color camera). Medial thickness, medial area, and luminal area of the aorta were measured from 4 random sections throughout the specimen and quantified using MetaMorph in a blinded fashion.
Statistical Analysis
The values for each parameter within a group are expressed as meanϮSEM. For comparisons between control and SMKO groups, statistical significance was assessed using an unpaired 2-tailed Student t test. A paired 2-tailed Student t test was used for comparisons within groups. P values Ͻ0.05 were considered significant. For blood pressure tracings measured over multiple days, 2-way ANOVA was performed followed by Bonferroni correction.
Results
Generation of Mice With Deletion of AT 1 Receptors From Smooth Muscle
We performed successive intercrosses between the SM22␣-Cre line and mice homozygous for the conditional "floxed" Agtr1a allele (Agtr1a flox/flox ) to generate SMKO mice and SM22␣-Cre --Agtr1a flox/flox (control) mice for experiments. To confirm elimination of AT 1A receptors from various vascular beds, levels of expression for AT 1A receptor mRNA were measured by real-time RT-PCR. Segments of aorta were isolated from SMKO and control mice, and the adventitia and endothelium were removed by dissection. As shown in Figure  1A , mRNA for the AT 1A receptor was easily detected in aortae from control mice but not from SMKO mice (PϽ0.0005). Similarly, AT 1A mRNA expression in mesenteric arteries, with intact endothelium and adventitia, was decreased by 60% in SMKO compared with control mice (PϽ0.05; Figure 1A ). Thus, in SMKO mice, AT 1A receptors are efficiently eliminated from VSMCs in conduit vessels. Further, no difference was seen in the relatively low levels of AT 1B receptor expression in aorta between the groups ( Figure 1B ).
Vasoconstrictor Responses Measured Ex Vivo
To functionally verify the efficiency of deletion of the AT 1A receptor from VSMCs, the contractile response of isolated vessels was assessed ex vivo. Isometric force was first measured after exposure to phenylephrine and then was independently measured to angiotensin II. Forces are expressed as a percentage of the maximal response to phenylephrine, which was equivalent between groups. As shown in Figure 2 , the contractile response to angiotensin II was significantly reduced by Ϸ75% in aortae from the SMKO compared with control mice (PՅ0.0005) consistent with the absence of AT 1A receptor mRNA ( Figure 1A) . Similarly, there was a corresponding reduction of Ϸ65% in the mesenteric artery segments from SMKO compared with control mice (PՅ0.05; Figure 2 ).
AT 1A mRNA Expression in Resistance Arteries
To examine AT 1A receptor expression in a preparation of resistance arteries, preglomerular arterioles were isolated from kidneys using the iron oxide-sieving technique. 21 Based on microscopic examination ( Figure 3A ) and augmented mRNA expression of VSMC markers such as ␣-smooth muscle actin ( Figure 3B ), there was marked enrichment for preglomerular vessels using this approach. However, unlike results with the aorta or mesenteric arteries, expression of AT 1A mRNA in preglomerular arterioles isolated from SMKO mice was preserved at levels that were not significantly different from controls, indicating lack of efficient excision of the floxed Agtr1a gene in these segments (PϭNS; Figure 3C ).
Acute Responses to Vasoconstrictors
We next compared acute vasoconstrictor responses in SMKO and control mice in vivo. As shown in Figure 4 , we observed robust acute vasoconstriction in the controls in response to escalating doses of angiotensin II from 0.1 to 10 g/kg. The magnitude of vasoconstriction was dose proportional and virtually identical in SMKO and control mice. Preservation of a normal vasoconstrictor response to angiotensin II in the SMKO mice is consistent with their unmodified expression of AT 1A receptors in resistance vessels ( Figure 3C ). The AT 1A receptor is deleted from conduit vessels. A, Real-time PCR performed on aorta stripped of adventitia and endothelium showed that mRNA for the AT 1A receptor was easily detected in aortae from control mice (black bars) but not from SMKO mice (white bars; nՆ3; ***PϽ0.0005 vs control). AT 1A mRNA expression in mesenteric arteries, with intact endothelium and adventitia, was decreased by 60% in SMKO compared with control mice (nϭ5; *PϽ0.05). B, No difference was seen in AT 1B receptor expression in the aorta between SMKO and control mice (nϭ3; PϭNS).
Blood Pressure Homeostasis Is Not Affected in SMKO Mice
Radiotelemetry units were implanted into 8-to 12-week-old male SMKO and control mice to measure blood pressure in the conscious, unrestrained state. Mean arterial pressures measured over 5 days were virtually identical between SMKO and control mice fed a normal-salt (0.4% NaCl) diet (116Ϯ2 versus 116Ϯ1 mm Hg; nϭ11 in each group). Moreover, diurnal variation of blood pressure was not affected in SMKO mice (data not shown).
Blood Pressure Responses in Angiotensin II-Dependent Hypertension
The preceding studies suggest that AT 1A receptors are effectively deleted from VSMCs in the aorta in SMKO mice, but their blood pressure responses to angiotensin II are preserved. Thus, we reasoned that the SMKO mice would be a useful model for separating the relative contributions of hypertension from direct actions of AT 1A receptors in VSMCs to aortic remodeling. To induce vascular remodeling, osmotic mini-pumps were implanted subcutaneously to infuse angiotensin II at 1000 ng/kg/min while blood pressures were continuously monitored. 27, 28 As shown in Figure 5 , the blood pressure responses to chronic angiotensin II infusion were very similar in the SMKO and control mice. Mean arterial pressure increased significantly by Ϸ30 mm Hg in both groups and remained elevated to an equivalent extent throughout the period of the infusion. Further, there was no difference in MAP between the groups averaged for the duration of angiotensin II administration (157Ϯ6 mm Hg versus 153Ϯ6 mm Hg).
Vascular Oxidative Stress
To examine levels of oxidative stress specifically in the vasculature, we assessed oxidation of proteins in the vascular wall. To this end, we isolated vascular wall proteins from thoracic aortic segments of control and SMKO mice. After hydrolyzing the proteins with acid, Blood pressure was measured continuously while increasing doses of angiotensin II (0.1 to 10 g/kg) were administered at 5-to 10-minute intervals. No difference was seen in peak pressor response at any dose between SMKO and control mice (PϭNS at 0.1 g/kg, 1 g/kg, and 10 g/kg doses; nϭ6 for both groups). MAP indicates mean arterial pressure.
amino acids were isolated as described previously. 26,29 -31 We then determined the content of the 2 oxidized amino acids, 3-nitrotyrosine and dityrosine, "molecular signatures" characteristic of peroxynitrite-mediated oxidation, by isotope dilution liquid chromatography tandem mass spectrometry. As shown in Figure 6A and 6B, increased levels of both 3-nitrotyrosine and dityrosine were detected in aortic segments from control mice after angiotensin II infusion. This increase was significantly attenuated in SMKO mice by Ϸ50% for dityrosine (137Ϯ27 versus 74Ϯ10 mol/mol tyrosine; PϽ0.05) by Ϸ80% for 3-nitrotyrosine (7819Ϯ1676 versus 1768Ϯ450 mol/mol tyrosine; PϽ0.005). To examine ROS generation in the vasculature, we measured local production of hydrogen peroxide using amplex red in freshly prepared thoracic aortae from control and SMKO mice at baseline. 
Vascular Responses in Angiotensin II-Dependent Hypertension
To determine the extent of vascular remodeling associated with the angiotensin II infusion, medial thickness and medialto-luminal area ratio of thoracic aortic sections were measured by morphometry. As shown in Figure 7 , there were no differences between control and SMKO mice at baseline, suggesting that the absence of AT 1A receptors in VSMCs does not significantly impact normal development and structure of the aorta. After 4 weeks of angiotensin II infusion, there was significant remodeling of the aorta in control mice, reflected by an increase in medial thickness from 27.7Ϯ1.9 m at baseline to 50.5Ϯ2.4 m ( Figure 7E ; PϽ0.0005) and an increase in medial-to-lumen ratio from 0.38Ϯ0.08 at baseline to 0.67Ϯ0.03 ( Figure 7F ; PϽ0.05). Similar increases in medial expansion (26.6Ϯ2.9 m versus 47Ϯ4.6 m; PϽ0.005) and medial-to-lumen ratio (0.36Ϯ0.07 versus 0.62Ϯ0.05;PϽ0.05) were seen in the SMKO mice with angiotensin II infusion, such that after angiotensin II infusion, these parameters were virtually identical in SMKO and control mice ( Figure 7C-7F ).
Discussion
Vascular remodeling and injury are typical features of endorgan damage from hypertension, contributing to clinical morbidity and mortality. 14 In the kidney, vascular lesions, interstitial fibrosis, and arteriosclerosis are the defining characteristics of hypertensive nephrosclerosis, a common cause of chronic kidney disease. 12 In larger vessels such as the aorta, vascular remodeling in hypertension produces changes in compliance resulting in increased pulse pressure, which has been associated with enhanced cardiovascular risk. 32, 33 Medial thickening of the carotid artery has been similarly . VSMC-specific AT 1A receptor mice have reduced local oxidative stress in the vascular wall after 4 weeks of angiotensin II-dependent hypertension. Oxidized amino acids in freshly dissected thoracic aorta were quantified by liquid chromatography-electrospray ionization tandem mass spectrometry using multiple reaction monitoring mode in SMKO (nϭ11) and control (nϭ13) mice after 4 weeks of angiotensin II administration. Increased levels of both 3-nitrotyrosine (A) and dityrosine (B) were detected in aortic segments from control mice after angiotensin II infusion. These increases were significantly attenuated in SMKO mice by Ϸ80% for 3-nitrotyrosine (7819Ϯ1676 vs 1768Ϯ450 mol/mol tyrosine; **PϽ0.005) and by Ϸ50% for dityrosine (137Ϯ27 vs 74Ϯ10 mol/mol tyrosine; #PϽ0.05).
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associated with increased cardiovascular risk and is commonly used as a surrogate marker for vascular outcomes in clinical trials. 34 The RAS is a major determinant of vascular function and pathology. 35 For example, angiotensin II acting through the AT 1 angiotensin receptor causes potent vasoconstriction. 16 This vasoconstrictor response is mediated by activation of AT 1 receptors in VSMCs, triggering increased intracellular calcium leading to myosin phosphorylation. 36 Along with these physiological effects, activation of the RAS also promotes vascular remodeling in patients with hypertension. 18 In smaller vessels, these structural changes can have hemodynamic consequences. 18, 37 Further, activation of the RAS may also impact the development of atherosclerosis 38 and aortic aneurysms. 39 Many of the vascular consequences of AT 1 receptor activation seem to emanate from direct effects in VSMCs, but these have largely been characterized in cultured cell systems. 40, 41 The precise contribution of AT 1 receptors in VSMCs to vascular physiology and pathology in vivo has been difficult to define because pharmacological antagonists or conventional gene knockouts lower blood pressure and produce broad inhibition of AT 1 receptors across all tissues, including VSMCs. Accordingly, to examine their actions in isolation in the intact animal, we developed a mouse model to eliminate expression of AT 1A receptors specifically in smooth muscle using Cre-Loxp technology.
To excise the floxed Agtr1a allele from smooth muscle, we used the Sm22␣-Cre transgenic mouse line expressing Cre recombinase under control of the promoter of the Sm22␣ gene. 42 We found that AT 1A receptors were efficiently deleted from aorta and early branches of the mesenteric arteries in SMKO mice (Figure 1 ). However, there was little or no excision from resistance vessels, reflected by preserved acute pressor responses to angiotensin II ( Figure 4 ) and normal levels of AT 1A receptor mRNA expression in preglomerular vessels isolated from SMKO mice ( Figure 3C) . Further, the extent of excision from small resistance arteries could not be appreciably enhanced when the Sm22␣-Cre transgene was crossed onto an Agtr1a flox/null background (data not shown). Although previous studies have suggested that the Sm22␣ promoter drives expression in most smooth muscle lineages, including VSMCs, [43] [44] [45] the levels of expression in small resistance vessels have not been clearly documented. Our study indicates that deletion of a floxed allele from peripheral resistance vessels cannot be efficiently accomplished using this Cre transgene. Nonetheless, because AT 1A receptors were efficiently eliminated from VSMCs in the aorta but were preserved in resistance arteries, we reasoned that this SMKO model could be useful for separating the consequences of elevated blood pressure from direct actions of AT 1 receptors in VSMCs on aortic remodeling during hypertension. Indeed, the extent of blood pressure elevation with angiotensin II infusion was very similar in the SMKO and control mice ( Figure 5) .
One of the key pathways linked to AT 1 receptors in VSMCs is the generation of ROS. 46 In this regard, AT 1 . E and F, Aortic medial thickness was quantified using morphometry. E, There were no differences in medial thickness at baseline between the groups; medial thickness increased significantly and to a similar extent in control and SMKO mice during angiotensin II infusion. F, Ratios of medial to lumen areas were also similar in the 2 groups before and after 4 weeks of angiotensin II infusion (*PϽ0.005 vs control baseline; #PϽ0.005 vs SMKO baseline; P Ͻ0.05 vs control baseline; ϩPϽ0.05 vs SMKO baseline).
receptors activate NADPH oxidases (Nox1 and Nox4) in VSMCs 47, 48 generating ROS such as superoxide anion and H 2 O 2 , which may contribute to the pathogenesis of hypertension. 41, 49 Further, stimulation of ROS production by AT 1 receptors in cultured VSMCs has been associated with cellular hypertrophy. 50 To examine the capacity of AT 1A receptors to promote oxidative stress in vivo, we compared indices of oxidative stress between SMKO and control mice before and during chronic angiotensin II infusion. At baseline, we found reduced levels of hydrogen peroxide production by isolated aortic segments from SMKO compared with control mice. In addition, we found evidence for marked reductions in the levels of oxidized tyrosine residues (Figure 6 ). Excess O 2 ⅐-produced by NOX enzymes or uncoupled endothelial nitric oxide synthase can form H 2 O 2 or react with NO ⅐ to form the highly reactive oxidant peroxynitrite. 26, 51, 52 Along with contributing to oxidative stress, this reaction extinguishes the beneficial actions of NO in the vasculature. Moreover, peroxynitrite can oxidize tyrosine residues in the vascular wall, and this covalent alteration provides a footprint to assess the extent of oxidative stress over time. 53 Our findings of decreased 3-nitrotyrosine and dityrosine in SMKO mice after angiotensin II administration are consistent with decreased peroxynitrite formation by either of these mechanisms. 26, 30 Together, our data indicate a key role for AT 1 receptors in VSMCs to promote oxidative stress, as evidenced by the profound reduction in 3-nitrotyrosine and dityrosine in hypertension, independent of any concomitant effects of elevated blood pressure per se.
As discussed above, there exists ample evidence suggesting that generation of ROS by AT 1 receptor activation in VSMCs may have direct consequences on vascular structure and function. In this regard, several studies have shown that administration of potent antioxidant agents can attenuate angiotensin II-dependent hypertension. 54, 55 Our studies suggest that reduced oxidative stress in large conduit arteries alone is not sufficient to lower blood pressure. Instead, this may require more robust ROS inhibition in resistance arteries, the central nervous system, 56 or the kidney. 10 Moreover, the absence of AT 1A receptors and the dramatic diminution of oxidative stress in the aortic wall of the SMKO mice did not result in detectable attenuation of medial hypertrophy compared with control mice (Figure 7 ). This indicates that direct actions of AT 1A receptors in VSMCs, including generation of oxidative stress, are not required to induce aortic remodeling in this setting, and it is consistent with previous reports describing dissociations between levels of ROS generation and cardiac or aortic remodeling. [57] [58] [59] Because the severity of hypertension was similar in SMKO and control mice, we suggest that elevated blood pressure is the major mechanism driving medial expansion in this setting. This is in line with previous studies by our group and others documenting the dominant actions of blood pressure to drive end-organ damage in the heart and vasculature. 10, 60, 61 
Perspectives
Other factors, such as elevated blood pressure, may play a dominant role in hypertensive vascular remodeling because the extent of hypertension was very similar between the groups in our study. Alternatively, AT 1 receptor actions, including ROS generation, in other cell lineages such as endothelium or circulating inflammatory cells may have significant roles in hypertensive vascular remodeling. Further, our studies do not rule out the possibility that pathways linked to AT 1 receptors in VSMCs may contribute to the pathogenesis of more complex vascular lesions such as atherosclerosis or aneurysms, in which oxidative stress has also been implicated. 62 
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